Bibliografía

• Barco S, Pomero F, Di Minno MND, Tamborini Permunian E, Malato A, Pasca S, et al. Clinical course of patients with symptomatic isolated superficial vein thrombosis: the ICARO follow-up study. J Thromb Haemost. 2017;15:2176-83. [Pubmed]
• Bauersachs R, Gerlach HE, Heinken A, Hoffmann U, Langer F, Noppeney T, et al. Management and outcomes of patients with isolated superficial vein thrombosis under real life conditions (INSIGHTS-SVT). Eur J Vasc Endovasc Surg. 2021 Aug;62(2):241-9. [Pubmed]
• Beddar Chaib F, Jiménez Hernández S, Pedrajas Navas JM, Carriel Mancilla J, Castro Arias L, Merlo Loranca M, et al; Grupo de Enfermedad Tromboembólica Venosa de la Sociedad Española de Medicina de Urgencias y Emergencias (ETV-SEMES). Characteristics of isolated superficial vein thrombosis and diagnostic therapeutic management in Spanish hospital emergency departments: the ALTAMIRA study. Emergencias. 2021 Dec;33(6):433-40. [Pubmed]
• Beyer-Westendorf J, Schellong SM, Gerlach H, Rabe E, Weitz JI, Jersemann K, et al; SURPRISE investigators. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. Lancet Haematol. 2017 Mar;4(3):e105-e113. [Pubmed]
• Cosmi B, Filippini M, Tonti D, Avruscio G, Ghirarduzzi A, Bucherini E, et al; STEFLUX Investigators. A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum). J Thromb Haemost. 2012 Jun;10(6):1026-35. [Pubmed]
• Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, et al; CALISTO Study Group. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med. 2010 Sep 23;363(13):1222-32. [Pubmed]
• Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. 2018 Feb 25;2(2):CD004982. [Pubmed]
• Jiménez Hernández S, Ruiz Artacho P, Peiró Morant JF, Robledo Orduña, C, Rial Horcajo R, Moñux Ducajú G, et al. Respuestas en trombosis venosa superficial: De la bibliografía a la práctica. Madrid: Sanidad y Ediciones SL; 2020. pp. 37.
• Prandoni P, Tormene D, Pesavento R; Vesalio Investigators Group. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs: a double-blind, randomized trial. J Thromb Haemost. 2005;3:1152-7. [Pubmed]
• Stevens SM, Woller SC, Baumann Kreuziger L, Bounameaux H, Doerschug K, Geersing GJ, et al. Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest. 2021 Dec;160(6):2247-59. [Pubmed]